UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041336
Receipt number R000047196
Scientific Title A Prospective study, using the VersaOne Fascial Closure system during abdominal wall closure at port insertion site in laparoscopic surgery
Date of disclosure of the study information 2020/08/07
Last modified on 2021/02/11 18:11:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective study, using the VersaOne Fascial Closure system during abdominal wall closure at port insertion site in laparoscopic surgery

Acronym

A Prospective study, using the VersaOne Fascial Closure system during abdominal wall closure at port insertion site in laparoscopic surgery

Scientific Title

A Prospective study, using the VersaOne Fascial Closure system during abdominal wall closure at port insertion site in laparoscopic surgery

Scientific Title:Acronym

A Prospective study, using the VersaOne Fascial Closure system during abdominal wall closure at port insertion site in laparoscopic surgery

Region

Japan


Condition

Condition

gastrointestinal disease

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the safety and efficacy of the VersaOne Fascial Closure system

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fascial closure time of 12mm port

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Cases using a 12 mm port in cases undergoing laparoscopic surgery
2)A case in which the thickness from the skin to the peritoneum measured by CT is 30 mm or more at the planned port insertion site
3)Latest test results within 2 months prior to registration, maintaining organ function required for surgery under general anesthesia
4)Written consent has been obtained from the study participant
5)Excludes patients with a history of open surgery and previous wounds at the site of planned port insertion
6) Other cases considered inappropriate by the attending physician are excluded.

Key exclusion criteria

Patients with a history of previous laparotomy and a history of injury at the site where the port is to be inserted or other complications or treatment courses that the attending physician deems inappropriate

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Takemasa

Organization

Sapporo Medical University Hospital

Division name

Department of Surgery, Surgical Oncology and Science

Zip code

060-8556

Address

nishi 16 choume minami 1 jyo Chuo-ku Sapporo

TEL

0116112111

Email

itakemasa@sapmed.ac.jp


Public contact

Name of contact person

1st name Masayuki
Middle name
Last name Ishii

Organization

Sapporo Medical University Hospital

Division name

Department of Surgery, Surgical Oncology and Science

Zip code

060-8556

Address

nishi 16 choume minami 1 jyo Chuo-ku Sapporo

TEL

0116112111

Homepage URL


Email

masayuki-ishii@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Covidien Japan Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo medical university hospital institutional review board

Address

nishi 16 choume minami 1 jyo Chuo-ku Sapporo

Tel

0116112111

Email

ji-rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 06 Month 10 Day

Date of IRB

2020 Year 06 Month 11 Day

Anticipated trial start date

2020 Year 08 Month 07 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No special notes


Management information

Registered date

2020 Year 08 Month 06 Day

Last modified on

2021 Year 02 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047196


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name